Back

REDUCE LAP-HF I - Transcatheter InterAtrial Shunt Device for Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF I): 1-year Results from the Phase 2

27 August 2018 (16:45 - 16:53)
Organised by:
Congress Presentation Part of: Late Breaking Science in Heart Failure Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Ted Feldman

Evanston Hospital Northshore, Evanston (United States of America)

10 More presentations in this session

Presentation thumbnail
Panel discussants.
Video
Presentation thumbnail
Panel discussion.
Video
Presentation thumbnail
PROMIS-HFpEF - Microvascular dysfunction in heart failure with preserved ejection fraction (HFpEF): Evidence from the prospective multicenter PRevalence Of Microvascular dySfunction in HFpEF
Professor C. Lam (Singapore, SG)
Slides Video
Presentation thumbnail
Panel discussion.
Video
Presentation thumbnail
Safety and efficacy of neladenoson bialanate in patients with chronic heart failure and reduced ejection fraction.
Professor A. Voors (Groningen, NL)

Access the full session

Session thumbnail
Late Breaking Science in Heart Failure

The Event

Event poster

ESC Congress 2018

27 August 2018 16:45 CET
You may be interested in
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Webinar
Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources